The stock of Cambridge Cognition Holdings PLC (LON:COG) is a huge mover today! The stock decreased 2.10% or GBX 1.5 on November 24, hitting GBX 70. About 26,330 shares traded hands or 26.45% up from the average. Cambridge Cognition Holdings PLC (LON:COG) has risen 72.29% since April 25, 2016 and is uptrending. It has outperformed by 66.88% the S&P500.
The move comes after 9 months positive chart setup for the GBX 14.11 million company. It was reported on Nov, 24 by Barchart.com. We have GBX 74.90 PT which if reached, will make LON:COG worth GBX 987,700 more.
Cambridge Cognition Holdings PLC (LON:COG) Ratings Coverage
Out of 2 analysts covering Cambridge Cognition Holdings (LON:COG), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Cambridge Cognition Holdings has been the topic of 20 analyst reports since July 23, 2015 according to StockzIntelligence Inc. The company was maintained on Wednesday, July 20 by FinnCap. FinnCap maintained Cambridge Cognition Holdings PLC (LON:COG) rating on Wednesday, June 22. FinnCap has “Corporate” rating and GBX 100 price target. On Thursday, May 5 the stock rating was maintained by FinnCap with “Corporate”. The company was maintained on Wednesday, March 16 by FinnCap. The firm has “Corporate” rating given on Thursday, October 8 by FinnCap. The company was maintained on Tuesday, August 30 by FinnCap. The firm has “Corporate” rating by FinnCap given on Thursday, September 22. The stock has “Corporate” rating given by FinnCap on Thursday, September 10. The rating was maintained by FinnCap with “Corporate” on Thursday, June 2. The firm earned “Corporate” rating on Monday, April 4 by FinnCap.
More recent Cambridge Cognition Holdings PLC (LON:COG) news were published by: Uk.Finance.Yahoo.com which released: “-LSE Ticker: 8DV964/ISIN: GB00B8DV9647” on March 16, 2014. Also Businesswire.com published the news titled: “Cambridge Cognition: First Showing of Groundbreaking Mental Health Wearable …” on April 06, 2016. Reuters.com‘s news article titled: “BRIEF-Cambridge Cognition says CEO Nick Kerton to take leave of absence” with publication date: July 01, 2015 was also an interesting one.
Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The company has a market cap of 14.11 million GBP. The Company’s divisions include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. It currently has negative earnings. The Pharmaceutical Clinical Trials segment includes services and products for use in regulated pharmaceutical clinical trials.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.